52

Sandu Pharmaceuticals LtdBOM 524703 Stock Report

Last reporting period 31 Mar, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.003

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Sandu Statements

52

Sandu Income Statement

B

M

INR (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2024-03-31
%

330.26

100

148.26

44.9

182

55.1

0

50.037

15.2

174.14

52.7

7.863

2.4

-0.249

-0.08

3.359

1

10.973

3.3

2.962

0.9

8.01

2.4

0.83

9.709

2023-09-30
%

342.64

100

177.44

50

165.2

50

0

50.695

15.3

155.93

45.9

9.268

4.2

-0.382

-0.09

0.881

0.5

9.767

4.6

3.153

1.3

6.613

3.3

0.68

9.825

2023-03-31
%

323.57

100

136.93

40.8

186.65

59.2

0

59.339

20.1

176.28

57

10.364

2.3

-0.343

-0.1

0.726

0.3

10.747

2.5

3.216

0.7

7.531

1.8

0.782

9.709

2022-09-30
%

329.92

100

174.98

52.2

154.94

47.8

0

51.614

16.5

145.61

43.4

9.328

4.4

-0.453

-0.1

2.544

1

11.419

5.2

3.746

1.7

7.676

3.6

0.859

9.108

2022-03-31
%

305.74

100

148.9

32

156.84

68

0

41.816

16.1

146.1

64.1

10.739

3.9

-0.236

-0.2

0.315

0.2

10.818

3.9

3.631

1.6

7.183

2.4

0.83

9.085

2021-09-30
%

349.26

100

208.53

56.9

140.74

43.1

0

47.303

14.6

128.03

39.3

12.702

3.8

-0.863

-0.3

0.513

0.2

12.352

3.7

3.639

1.1

8.712

2.6

1.1

7.921

2021-03-31
%

140.95

100

69.093

49

71.861

51

0

14.389

10.2

65.021

46.1

6.84

4.9

-0.577

-0.4

0.308

0.2

6.571

4.7

2.926

2.1

3.645

2.6

0.51

7.148

View Section: Balance Sheet